- Home
- » Tags
- » Labetuzumab
Top View
- Stembook 2018.Pdf
- NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
- IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
- (INN) for Biological and Biotechnological Substances
- WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
- WHO Drug Information Vol
- (12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
- Emtree Terms Changed in September 2013
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy
- International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
- Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in A
- Mai Muita in Acut Ca Uti on Muunni
- Antibody-Drug Analogues
- Humanised Igg1 Antibody Variants Targeting Membrane-Bound Carcinoembryonic Antigen by Antibody-Dependent Cellular Cytotoxicity and Phagocytosis
- Pharmaabkommen A1 E
- Antibody-Drug Conjugate (Adc) and Method for Forming the Same
- Biotechnology Presented by America’S Biopharmaceutical Research Companies
- Customs Tariff - Schedule Xxi - 1
- Antibody Therapy of Cancer
- (12) United States Patent (10) Patent No.: US 9,107,960 B2 Govindan Et Al
- Prescrire Contribution to Proposed INN List
- Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model
- IMSN Open Letter on Antibody-Drug Conjugate 2151012
- (12) United States Patent (10) Patent No.: US 9,345,770 B2 Storkus Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Towards the Development of Biobetter Therapeutic Whole Antibodies
- Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
- Patient Selection Strategies to Maximize Therapeutic Index Of
- In Oncology Lacey R
- Radiomarquage Au 99Mtc Des Iga Et Igg : Optimisation Du Marquage, Étude in Vitro, Biodistribution Chez L’Animal Sain Et Sur Modèle Tumoral Hélène Carpenet Guéry
- 1770.Full-Text.Pdf
- (INN) for Biological and Biotechnological Substances
- Impact of Different Selectivity Between Soluble and Membrane-Bound Forms of Carcinoembryonic Antigen (CEA) on the Target-Mediate
- Panitumumab Modified with Metal Chelating Polymers (Mcps) Complexing Indium‐111 and Lutetium-177 As Theranostics for Pancreatic Cancer
- Assessment of the Evolution of Cancer Treatment Therapies
- Impact of Different Selectivity Between Soluble and Membrane-Bound Forms Of
- A Humanized Monoclonal Antibody to Carcinoembryonic Antigen
- Immunomedics,® Inc
- Human BMPR1B Amino Acid Sequence